PDS Biotech Announces Agreement With University Of Georgia To License Novel Proteins For Versamune-Based Universal Flu Vaccine
PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell